<?xml version="1.0" encoding="UTF-8"?>
<ref id="B166">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Shiraki</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Daikoku</surname>
    <given-names>T.</given-names>
   </name>
  </person-group> (
  <year>2020</year>). 
  <article-title>Favipiravir, an anti-influenza drug against life-threatening RNA virus infections</article-title>. 
  <source>Pharmacol. Ther.</source>
  <volume>209</volume>:
  <fpage>107512</fpage>. 
  <pub-id pub-id-type="doi">10.1016/j.pharmthera.2020.107512</pub-id>
  <?supplied-pmid 32097670?>
  <pub-id pub-id-type="pmid">32097670</pub-id>
 </mixed-citation>
</ref>
